In this episode, we cover the U.S. Food and Drug Administration’s draft guidance clarifying its authority to access records related to cosmetic products under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Issued on January 22, 2026, this draft guidance explains how the FDA may access and copy records — including adverse event reports, manufacturing and distribution documentation, safety substantiation data, and complaint records — during inspections or when a cosmetic p...